Kassinin
| Internal ID | e1e59822-ef00-4ab5-9bdd-758a072217ec |
| Taxonomy | Organic Polymers > Polypeptides |
| IUPAC Name | 3-amino-4-[[1-[2-[[6-amino-1-[[1-[[1-[[5-amino-1-[[1-[[1-[[2-[[1-[(1-amino-4-methylsulfanyl-1-oxobutan-2-yl)amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]amino]-4-oxobutanoic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C59H95N15O18S/c1-30(2)24-38(53(86)66-35(49(63)82)20-23-93-7)65-44(77)28-64-58(91)47(31(3)4)72-55(88)39(25-33-14-9-8-10-15-33)69-52(85)37(18-19-43(62)76)67-54(87)40(27-46(80)81)70-56(89)41(29-75)71-51(84)36(16-11-12-21-60)68-57(90)42-17-13-22-74(42)59(92)48(32(5)6)73-50(83)34(61)26-45(78)79/h8-10,14-15,30-32,34-42,47-48,75H,11-13,16-29,60-61H2,1-7H3,(H2,62,76)(H2,63,82)(H,64,91)(H,65,77)(H,66,86)(H,67,87)(H,68,90)(H,69,85)(H,70,89)(H,71,84)(H,72,88)(H,73,83)(H,78,79)(H,80,81) |
| InChI Key | NXTPETCPVNEEOP-UHFFFAOYSA-N |
| Popularity | 87 references in papers |
| Molecular Formula | C59H95N15O18S |
| Molecular Weight | 1334.50 g/mol |
| Exact Mass | 1333.67002241 g/mol |
| Topological Polar Surface Area (TPSA) | 570.00 Ų |
| XlogP | -7.50 |
| Atomic LogP (AlogP) | -5.04 |
| H-Bond Acceptor | 19 |
| H-Bond Donor | 17 |
| Rotatable Bonds | 43 |
| 63968-82-1 |
| GTPL2088 |
| SCHEMBL20639320 |
| BDBM81943 |
| DTXSID50895029 |
| CAS_45749 |
| NSC_45749 |
| Q6374755 |
| alpha-aspartylvalylprolyllysylseryl-alpha-aspartylglutaminylphenylalanylvalylglycylleucylmethioninamide |
| CID45749; Kassinin; L-alpha-aspartyl-L-valyl-L-prolyl-L-lysyl-L-seryl-L-alpha-aspartyl-L-glutaminyl-L-phenylalanyl-L-valyl-glycyl-L-leucyl-L-methioninamide |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.6302 | 63.02% |
| Caco-2 | - | 0.8656 | 86.56% |
| Blood Brain Barrier | - | 0.8500 | 85.00% |
| Human oral bioavailability | - | 0.6714 | 67.14% |
| Subcellular localzation | Lysosomes | 0.5333 | 53.33% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8398 | 83.98% |
| OATP1B3 inhibitior | + | 0.9309 | 93.09% |
| MATE1 inhibitior | - | 0.9000 | 90.00% |
| OCT2 inhibitior | - | 0.9250 | 92.50% |
| BSEP inhibitior | + | 0.9686 | 96.86% |
| P-glycoprotein inhibitior | + | 0.7421 | 74.21% |
| P-glycoprotein substrate | + | 0.8779 | 87.79% |
| CYP3A4 substrate | + | 0.7428 | 74.28% |
| CYP2C9 substrate | - | 0.7948 | 79.48% |
| CYP2D6 substrate | - | 0.8241 | 82.41% |
| CYP3A4 inhibition | - | 0.9611 | 96.11% |
| CYP2C9 inhibition | - | 0.9181 | 91.81% |
| CYP2C19 inhibition | - | 0.8621 | 86.21% |
| CYP2D6 inhibition | - | 0.9175 | 91.75% |
| CYP1A2 inhibition | - | 0.9053 | 90.53% |
| CYP2C8 inhibition | + | 0.7163 | 71.63% |
| CYP inhibitory promiscuity | - | 0.9860 | 98.60% |
| UGT catelyzed | - | 0.6000 | 60.00% |
| Carcinogenicity (binary) | - | 0.8500 | 85.00% |
| Carcinogenicity (trinary) | Non-required | 0.6688 | 66.88% |
| Eye corrosion | - | 0.9872 | 98.72% |
| Eye irritation | - | 0.8961 | 89.61% |
| Skin irritation | - | 0.7846 | 78.46% |
| Skin corrosion | - | 0.9245 | 92.45% |
| Ames mutagenesis | - | 0.8100 | 81.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.6894 | 68.94% |
| Micronuclear | + | 0.7300 | 73.00% |
| Hepatotoxicity | - | 0.5527 | 55.27% |
| skin sensitisation | - | 0.8757 | 87.57% |
| Respiratory toxicity | + | 0.8778 | 87.78% |
| Reproductive toxicity | + | 0.8778 | 87.78% |
| Mitochondrial toxicity | + | 0.9125 | 91.25% |
| Nephrotoxicity | - | 0.7804 | 78.04% |
| Acute Oral Toxicity (c) | III | 0.6258 | 62.58% |
| Estrogen receptor binding | + | 0.6532 | 65.32% |
| Androgen receptor binding | + | 0.6473 | 64.73% |
| Thyroid receptor binding | + | 0.6373 | 63.73% |
| Glucocorticoid receptor binding | + | 0.7347 | 73.47% |
| Aromatase binding | + | 0.7449 | 74.49% |
| PPAR gamma | + | 0.7287 | 72.87% |
| Honey bee toxicity | - | 0.7377 | 73.77% |
| Biodegradation | - | 0.8500 | 85.00% |
| Crustacea aquatic toxicity | - | 0.5200 | 52.00% |
| Fish aquatic toxicity | + | 0.7604 | 76.04% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.98% | 98.95% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 99.81% | 98.33% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 99.00% | 98.10% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 98.76% | 89.63% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 98.72% | 90.17% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.57% | 96.09% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 98.56% | 90.20% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 98.42% | 100.00% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 98.35% | 96.67% |
| CHEMBL4801 | P29466 | Caspase-1 | 98.32% | 96.85% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 97.55% | 91.11% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 97.55% | 98.24% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 97.53% | 98.94% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 97.35% | 93.00% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 97.30% | 88.42% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 96.86% | 96.03% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 96.85% | 82.69% |
| CHEMBL4625 | Q07817 | Apoptosis regulator Bcl-X | 96.81% | 99.77% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 96.76% | 96.67% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 96.68% | 97.64% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 96.64% | 93.56% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 96.41% | 97.23% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 96.21% | 97.09% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 95.97% | 100.00% |
| CHEMBL3024 | P53350 | Serine/threonine-protein kinase PLK1 | 95.34% | 97.43% |
| CHEMBL3468 | P55210 | Caspase-7 | 94.77% | 95.68% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 94.69% | 98.89% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 94.30% | 99.17% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 94.26% | 97.14% |
| CHEMBL236 | P41143 | Delta opioid receptor | 93.51% | 99.35% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 93.42% | 90.71% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 91.98% | 95.56% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 91.51% | 96.00% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 90.97% | 91.19% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 90.47% | 100.00% |
| CHEMBL1873 | P00750 | Tissue-type plasminogen activator | 90.25% | 93.33% |
| CHEMBL4581 | P52732 | Kinesin-like protein 1 | 89.82% | 93.18% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 89.39% | 93.10% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 89.18% | 97.50% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 88.42% | 96.47% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 88.40% | 95.38% |
| CHEMBL3018 | Q9Y5Y6 | Matriptase | 88.33% | 98.33% |
| CHEMBL5939 | Q9NZ08 | Endoplasmic reticulum aminopeptidase 1 | 88.25% | 100.00% |
| CHEMBL2095164 | P49354 | Geranylgeranyl transferase type I | 88.21% | 92.80% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 87.92% | 95.89% |
| CHEMBL204 | P00734 | Thrombin | 87.62% | 96.01% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 87.27% | 93.03% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 87.19% | 97.21% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 86.39% | 94.45% |
| CHEMBL5261 | Q7L7X3 | Serine/threonine-protein kinase TAO1 | 86.37% | 89.33% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 85.56% | 91.81% |
| CHEMBL2319 | P06870 | Kallikrein 1 | 85.23% | 90.95% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 85.10% | 94.66% |
| CHEMBL5701 | Q9H2K8 | Serine/threonine-protein kinase TAO3 | 84.71% | 96.67% |
| CHEMBL249 | P25103 | Neurokinin 1 receptor | 84.58% | 99.17% |
| CHEMBL3004 | P33527 | Multidrug resistance-associated protein 1 | 84.01% | 96.37% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 83.67% | 94.00% |
| CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit | 83.46% | 82.86% |
| CHEMBL2073 | P07947 | Tyrosine-protein kinase YES | 83.13% | 83.14% |
| CHEMBL2001 | Q9H244 | Purinergic receptor P2Y12 | 82.96% | 96.00% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 82.95% | 95.00% |
| CHEMBL5028 | O14672 | ADAM10 | 82.89% | 97.50% |
| CHEMBL2803 | P43403 | Tyrosine-protein kinase ZAP-70 | 81.91% | 82.50% |
| CHEMBL3837 | P07711 | Cathepsin L | 81.67% | 96.61% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 81.42% | 82.38% |
| CHEMBL2535 | P11166 | Glucose transporter | 80.52% | 98.75% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 45749 |
| LOTUS | LTS0194692 |
| wikiData | Q6374755 |